Teacher Retirement System of Texas Acquires 156,947 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Teacher Retirement System of Texas grew its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHFree Report) by 232.8% during the third quarter, HoldingsChannel.com reports. The firm owned 224,375 shares of the company’s stock after buying an additional 156,947 shares during the period. Teacher Retirement System of Texas’ holdings in Aveanna Healthcare were worth $1,990,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Quantbot Technologies LP acquired a new position in Aveanna Healthcare in the second quarter valued at about $43,000. MQS Management LLC acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at approximately $59,000. Belvedere Trading LLC bought a new position in Aveanna Healthcare during the 2nd quarter worth approximately $62,000. Oxford Asset Management LLP bought a new position in Aveanna Healthcare during the 2nd quarter worth approximately $64,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Aveanna Healthcare in the second quarter valued at approximately $68,000. Institutional investors own 87.96% of the company’s stock.

Insider Buying and Selling

In related news, insider Edwin C. Reisz sold 17,613 shares of the business’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $138,262.05. Following the transaction, the insider directly owned 1,321,114 shares in the company, valued at approximately $10,370,744.90. The trade was a 1.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jeff Shaner sold 29,357 shares of the company’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $230,452.45. Following the sale, the chief executive officer directly owned 2,394,179 shares in the company, valued at $18,794,305.15. This trade represents a 1.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 259,638 shares of company stock worth $2,109,595 over the last 90 days. Company insiders own 7.80% of the company’s stock.

Aveanna Healthcare Trading Up 0.7%

Shares of NASDAQ:AVAH opened at $8.40 on Friday. The company’s 50-day moving average price is $8.85 and its two-hundred day moving average price is $8.06. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The stock has a market capitalization of $1.75 billion, a PE ratio of 23.33 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) last released its earnings results on Thursday, November 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.08. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $621.94 million for the quarter, compared to the consensus estimate of $578.57 million. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on AVAH shares. Raymond James Financial reissued an “outperform” rating and set a $13.00 price target on shares of Aveanna Healthcare in a research report on Friday, December 5th. Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research report on Thursday, January 15th. UBS Group boosted their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, January 15th. Truist Financial raised their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $11.06.

View Our Latest Report on Aveanna Healthcare

Aveanna Healthcare Profile

(Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Further Reading

Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHFree Report).

Institutional Ownership by Quarter for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.